| Literature DB >> 35967306 |
John Onyebuchi Ogbodo1, Amarachukwu Vivan Arazu1, Tochukwu Chisom Iguh2, Ngozichukwuka Julie Onwodi3, Tobechukwu Christian Ezike4.
Abstract
The etiopathogenesis of inflammatory and autoimmune diseases, including pulmonary disease, atherosclerosis, and rheumatoid arthritis, has been linked to human exposure to volatile organic compounds (VOC) present in the environment. Chronic inflammation due to immune breakdown and malfunctioning of the immune system has been projected to play a major role in the initiation and progression of autoimmune disorders. Macrophages, major phagocytes involved in the regulation of chronic inflammation, are a major target of VOC. Excessive and prolonged activation of immune cells (T and B lymphocytes) and overexpression of the master pro-inflammatory constituents [cytokine and tumor necrosis factor-alpha, together with other mediators (interleukin-6, interleukin-1, and interferon-gamma)] have been shown to play a central role in the pathogenesis of autoimmune inflammatory responses. The function and efficiency of the immune system resulting in immunostimulation and immunosuppression are a result of exogenous and endogenous factors. An autoimmune disorder is a by-product of the overproduction of these inflammatory mediators. Additionally, an excess of these toxicants helps in promoting autoimmunity through alterations in DNA methylation in CD4 T cells. The purpose of this review is to shed light on the possible role of VOC exposure in the onset and progression of autoimmune diseases.Entities:
Keywords: VOC; autoimmune diseases; immune system and etiopathogenesis; proinflammatory mediators
Mesh:
Substances:
Year: 2022 PMID: 35967306 PMCID: PMC9373925 DOI: 10.3389/fimmu.2022.928379
Source DB: PubMed Journal: Front Immunol ISSN: 1664-3224 Impact factor: 8.786
Various volatile organic compound (VOC) types and their exposure phenotypes.
| Types of VOC/sources | Example | Exposure phenotype | References |
|---|---|---|---|
| Aromatic hydrocarbons: automobile exhaust fumes, gasoline evaporation, cigarette smoke, petroleum refining, a component of paint and printing ink ( | Benzene | Alterations in gene expression associated with apoptosis, metabolic oxidative stress, and inflammatory cytokine production (mice) | ( |
| Toluene | High doses affect IFN-ϒ, IL-4, and IL-13 production by activated T cells and increase TNF-α expression (human PBMCs) | ( | |
| Ethylbenzene | Associated with higher percentages of IL-4-producing CD3+ T cells (human) | ( | |
| Xylene | Generates ROS, triggers oxidative stress, and oxidant injury (human lymphocytes) | ( | |
| Styrene | Causes chromosomal aberrations, increase in monocytes, and cell adhesion molecules (mice) | ( | |
| Polycyclic aromatic hydrocarbons: incomplete fuel combustion, | Naphthalene | Triggers a considerable reduction in the number of CD3+/CD8+ peripheral T cells (human) | ( |
| Phenanthrene | Induces adaptive immune response changes (Th1/Th2-related cytokine release) (human) | ( | |
| Benzo[a]pyrene | Alters the development of T lymphocytes in offspring (mice) | ( | |
| Aldehydes: emission from interior decorative materials, cosmetics, cleaning agents, treated wood resins, plastic adhesives ( | Formaldehyde | Reduces the number of NK cells, regulatory T cells, and CD8+ effector memory T cells (human) | ( |
| Acetaldehyde | Modifies self-proteins and induces autoimmunity, resulting in increased inflammation | ( | |
| Chlorinated hydrocarbons: components of paints, rubbers, cleaning agents, formulation and processing of chemical extractants, drugs production ( | Dichloromethane | Induces IFN-related genes as part of the immune response which was then followed by the apoptosis pathway (human promyelocytic leukemia HL60 cells) | ( |
| 1,2-dichloroethane | Induces an overproduction of inflammatory factors in the brain (mice) | ( | |
| Vinyl chloride | Its metabolites induce organ injury | ( | |
| Trichloroethylene | Increases CD4+ and CD8+ T cell populations (mice) | ( | |
| Chlorobenzene | Associated with higher percentages of IL-4-producing CD3+ T cells (human) | ( | |
| Alcohols: cosmetics and personal care products such as nail polish, nail polish removers, colognes, perfumes, rubbing alcohol, and hair spray | Ethyl alcohol | Excessive consumption decreases the number of peripheral T cells, disturbs the balance of distinct T cell types, impacts T cell activation, inhibits T cell function, and increases T cell death (human and animal model) | ( |
| Ketones: aerosols, varnishes, window cleaners, paint thinners, plastics, and | Polymethyl-methacrylate | Alters immune cell function and deters host response to antigenic stimuli (mice) | ( |
| Methyl ethyl ketone | Induces the secretion of proinflammatory cytokines (humans) | ( |
Transcription factors and inflammatory mediators involved in inflammation and oxidative stress.
| Transcription factors/inflammatory mediators | Biological roles | References |
|---|---|---|
| Transcription factors | ||
| Nuclear factor-kappa B (NF-κB) | Initiates the expression of inflammatory genes, inflammasome regulation, innate immune cells and inflammatory T cell regulation, and differentiation | ( |
| Activator protein 1 (AP-1) | Initiates cell differentiation, survival, apoptosis, and cytokine expression | ( |
| Hypoxia-inducible factor 1-alpha (HIF-1α) | Induces host immune function, vascularization, angiogenesis, cell migration, and tumor invasion | ( |
| Nuclear factor erythroid 2-related factor 2 (Nrf-2) | Induce the expression of antioxidant enzymes in response to oxidant exposure; inhibits inflammation | ( |
| Tumor protein p53 | Controls cell division and apoptosis, tumor suppression, and DNA repair | ( |
| Peroxisome proliferator-activated receptor gamma (PPAR-γ) | Adipocyte regulation; blocks the expression of inflammatory cytokines and initiates immune cell differentiation | ( |
| Cytokines | ||
| Tumor necrosis factor (TNF-α and TNF-β) | Acts as an amplifier of inflammation; recruits neutrophils and macrophages | ( |
| Interleukins | Pro-inflammatory and anti-inflammatory; promotes activation and differentiation of immune cells, including proliferation, migration, and adhesion | ( |
| Transforming growth factors (TGF-α and TGF-β) | Regulates immune cells; inhibits growth and activation | ( |
| Chemokines | ||
| Monocyte chemoattractant protein (MCP-1 and -3) | Promotes monocyte migration | ( |
| Macrophage inflammatory protein-1 (MIP-1α) | Macrophage activation; recruitment of leucocytes to the site of inflammation | ( |
| RANTES (regulated on activation, normal T-expressed and secreted, CCL5) | Immune cell migration | ( |
Figure 1Proposed mechanism of volatile organic compound-induced inflammatory response and autoimmune diseases. Black solid arrows represent known pathways, and the black dashed arrows show an assumed mechanism, thus requiring future research.
Figure 2Common autoimmune diseases associated with VOC exposure.
Figure 3Immune response is triggered by genetic and environmental factors in the pathogenesis of rheumatoid arthritis (RA). The triggering process causes citrullination of target proteins found throughout the body, which results in the production of autoantibodies (ACPA) against citrullinated neoantigens. Increased levels of citrullinated neoantigens activate MHC class-II-dependent T cells to support B cells in producing more ACPA, which trigger cytokine production by recruiting other immune cells to the synovial joint, resulting in RA.
Figure 4Immune response triggered by genetic and environmental factors in the pathogenesis of systemic lupus erythematosus. Apoptosis is induced by the triggering agent through cascades of cellular signaling and inflammatory responses. The apoptotic autoantigens released during the process activate antigen-presenting cells (APCs) and neutrophils, promoting thrombosis and tissue damage. Activated APC causes T cells to produce cytokines and B cells to produce other antibodies and complexes, resulting in tissue damage.
DNA methylation alterations in autoimmune disease.
| Autoimmune disease | DNA methylation/alteration | VOCs linked with DNA methylation/alteration | Consequences | Examples of affected genes |
|---|---|---|---|---|
| Lupus | Hypomethylation | Acetonitrile, toluene, hexane, 2-methylpentane, methyl cyclopentane and 3-methylpentanetoluene, benzene, xylene, mercury, vinyl chloride, perchloroethylene, trichloroethylene, and crystalline silica | Gene activation |
|
| Lupus | Hypermethylation | Cadmium, vinyl chloride, perchloroethylene, trichloroethylene, smoking, silica dust, pesticides, and exposure to livestock | Gene silencing |
|
| Rheumatoid arthritis | Hypomethylation | Crystalline silica, vinyl chloride, perchloroethylene, trichloroethylene, and smoking | Gene activation |
|
| Type 1 diabetes | Hypermethylation | Toluene, benzene, xylene, petroleum hydrocarbon products, fuel vapor, and gasoline | Gene silencing | Insulin and |
| Vitiligo | Hypermethylation | Monobenzyl ether of hydroquinone or monobenzone | Gene activation |
|
| Pernicious anemia (PA) | Hypermethylation | Petroleum hydrocarbon products, fuel vapor, and gasoline | Gene activation | Many genes are affected depending on the type of PA such as |
| Vasculitis | Hypermethylation | New building scent and nitric acid | Gene activation |
|
| Alopecia areata | Hypermethylation | Cooling and heating systems and household goods | Gene activation |
|